About US
Contact us
-
ROQUETTE goes EXCiPACT™ to serve its pharmaceuticals customersROQUETTE granted EXCiPACT™, certifying its Good Manufacturing Practices implementation E.U. and U.S. pharmaceutical regulations require drug manufacturers to audit all their starting mat2016/4/21
-
FDA speeds ahead with new generic approvals in 2015: ReportThe FDA is finally seeing the fruits of its labor under a program meant to speed up approvals for generic drugs. The agency approved more generics in 2015 than any year prior and made strides toward a2016/4/21
-
WHO advisory group recommends use of Sanofi's dengue vaccine DengvaxiaThe World Health Organisation's (WHO) Strategic Advisory Group of Experts (SAGE) on immunisation has recommended the use of Sanofi's dengue vaccine, Dengvaxia. Dengvaxia is the first vaccine in the w2016/4/20
-
Australian researchers confirm Atovaquone's ability to combat malaria parasiteResearchers at the University of Melbourne, Australia, have discovered that an anti-malarial drug called Atovaquone, which was thought to be ineffective, has the ability to combat the malaria parasite2016/4/20
-
Deals this week: GE Ventures, Shanghai Fosun Pharma, Cambrooke TherapeuticsGE Venturesand Mayo Clinic have created a new joint venture (JV) company called Vitruvian Networks, Inc., which will expedite the treatment of cancer and other diseases by providing therapy producers2016/4/19
-
M&A this week: Advantis, Sequence Therapy, Madrigal Pharma, Synta PharmaAdvantis Corp.,has acquired a 25% stake in US-based pain management and physical therapy company Sequence Therapy, LLC, which sees an exponential growth in revenue, from the current $0.5m a year, with2016/4/19
-
Roche's atezo gets FDA fast track, BMS, Merck showdown comingWatch out,KeytrudaandOpdivo: Rochesnagged anotherFDApriority review for its cancer immunotherapy atezolizumab, this time in lung cancer. The Swiss drugmaker has big plans for the therapy, including an2016/4/18
-
Pfizer delay, alleged price gouging earns wrath of British watchdogIn case anyone thought it was just the U.S. where pharma has been accused of hiking prices, the U.K. has been quick to remind everyone it happens across the pond as well, after hitting Pfizer ($PFE) w2016/4/18
-
New study identifies fertility app as effective alternative to contraceptive pillNaturalCycles, a new fertility app, could be an effective hormone-free alternative to contraceptive pill to prevent and monitor pregnancies, a recent study has revealed. Developed by Dr Elina Berglun2016/4/15
-
Nordic Nanovector and PSI to develop new ARCs to treat single cell leukaemiaAnti-cancer therapeutics developer Nordic Nanovector has entered into a collaboration with Paul Scherrer Institute (PSI) in Switzerland, to develop new antibody radionuclide conjugates (ARCs) for trea2016/4/15